Karuna Therapeutics (KRTX) Stock Forecast
Analyst ratings, price targets, and earnings estimates.
KRTX Analyst Ratings
Buy
Consensus
Based on 6 analysts in the past 3 months
KRTX Stock 12 Month Forecast
$0.00
▼
(-100.00%
Downside)
Highest Price Target
$330.00
(0.1%)
Average Price Target
$0.00
(-100.0%)
Lowest Price Target
$150.00
(-54.5%)
Based on 0 analysts in the last year
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High
$460.34M
Average
$267.34M
Low
$108.00M
10 analysts
Net Income Estimates
High
$-59.81M
Average
$-331.10M
Low
$-436.60M
10 analysts
EPS Estimates
High
$-1.62
Average
$-7.54
Low
$-11.81
9 analysts
Revenue Estimates
High
$722.03M
Average
$711.46M
Low
$700.90M
11 analysts
Net Income Estimates
High
$398.68M
Average
$37.76M
Low
$-243.84M
11 analysts
EPS Estimates
High
$10.79
Average
$0.50
Low
$-6.60
8 analysts
Revenue Estimates
High
$2.33B
Average
$1.41B
Low
$645.88M
5 analysts
Net Income Estimates
High
$867.19M
Average
$469.68M
Low
$138.72M
5 analysts
EPS Estimates
High
$23.46
Average
$12.71
Low
$3.75
6 analysts
Revenue Estimates
High
$4.05B
Average
$2.45B
Low
$1.12B
4 analysts
Net Income Estimates
High
$1.95B
Average
$1.05B
Low
$311.57M
4 analysts
EPS Estimates
High
$52.70
Average
$28.54
Low
$8.43
7 analysts
Latest Price Target Updates
| Date | Analyst | Firm | Price Target | Price When Posted | Upside |
|---|---|---|---|---|---|
| Dec 26, 2023 | Raghuram Selvaraju | H.C. Wainwright | $330.00 | $317.00 | 4.1% |
| Jan 05, 2023 | None | Piper Sandler | $285.00 | $198.46 | 43.6% |
| Aug 12, 2022 | Yatin Suneja | Guggenheim | $330.00 | $261.31 | 26.3% |
| Aug 08, 2022 | Paul Matteis | Stifel Nicolaus | $260.00 | $241.19 | 7.8% |
| Apr 27, 2022 | None | Mizuho Securities | $190.00 | $120.50 | 57.7% |
| Aug 05, 2021 | Jason McCarthy | Maxim Group | $150.00 | $117.81 | 27.3% |
Related Metrics
Explore detailed financial metrics and analysis for KRTX.